Emerging research suggest this peptide, a dual activator targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , could represent a notable development for weight loss . Initial patient tests have demonstrated substantial reductions in visceral tissue, conceivably outperforming other obesity treatments. Despite this, fur